Literature DB >> 19179452

Inductive and suppressive networks regulate TLR9-dependent gene expression in vivo.

Sven Klaschik1, Debra Tross, Dennis M Klinman.   

Abstract

Bacterial DNA expressing unmethylated CpG motifs binds to TLR9, thereby stimulating a broadly protective, innate immune response. Although CpG-mediated signal transduction has been studied, the scope of TLR9-dependent gene expression is incompletely understood. To resolve these issues, mice were treated with immunostimulatory CpG oligonucleotides (ODN) and splenic mRNA levels monitored from 30 min through 3 days by microarray. Through the unique application of bioinformatic analysis to these experimental data, this study is the first to describe the complex regulatory networks responsible for TLR9-mediated gene expression. Current results are the first to establish that CpG-induced stimulation of the innate immune system proceeds in multiple waves over time, and gene up-regulation is mediated by a small number of temporally activated "major inducers" and "minor inducers". An additional study of TNF knockout mice supports the conclusion that the regulatory networks identified by our bioinformatic analysis accurately identified CpG ODN-driven gene-gene interactions in vivo. Equally important, this work identifies the counter-regulatory mechanisms embedded within the signaling cascade that suppresses the proinflammatory response triggered in vivo by CpG DNA stimulation. Identifying these network interactions provides novel and global insights into the regulation of TLR9-mediated gene activation, improves our understanding of TLR-mediated host defense, and facilitates the development of interventions designed to optimize the nature and duration of the ensuing response.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19179452      PMCID: PMC2669411          DOI: 10.1189/jlb.1008671

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  51 in total

1.  Increased resistance against acute polymicrobial sepsis in mice challenged with immunostimulatory CpG oligodeoxynucleotides is related to an enhanced innate effector cell response.

Authors:  H Weighardt; C Feterowski; M Veit; M Rump; H Wagner; B Holzmann
Journal:  J Immunol       Date:  2000-10-15       Impact factor: 5.422

Review 2.  Toll-like receptors: critical proteins linking innate and acquired immunity.

Authors:  S Akira; K Takeda; T Kaisho
Journal:  Nat Immunol       Date:  2001-08       Impact factor: 25.606

3.  Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation.

Authors:  Yee Hwa Yang; Sandrine Dudoit; Percy Luu; David M Lin; Vivian Peng; John Ngai; Terence P Speed
Journal:  Nucleic Acids Res       Date:  2002-02-15       Impact factor: 16.971

Review 4.  Toll-like receptors in the induction of the innate immune response.

Authors:  A Aderem; R J Ulevitch
Journal:  Nature       Date:  2000-08-17       Impact factor: 49.962

5.  CpG oligodeoxynucleotides induce murine macrophages to up-regulate chemokine mRNA expression.

Authors:  S Takeshita; F Takeshita; D E Haddad; K J Ishii; D M Klinman
Journal:  Cell Immunol       Date:  2000-12-15       Impact factor: 4.868

6.  Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition.

Authors:  S Bauer; C J Kirschning; H Häcker; V Redecke; S Hausmann; S Akira; H Wagner; G B Lipford
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-24       Impact factor: 11.205

7.  Cutting edge: Role of Toll-like receptor 9 in CpG DNA-induced activation of human cells.

Authors:  F Takeshita; C A Leifer; I Gursel; K J Ishii; S Takeshita; M Gursel; D M Klinman
Journal:  J Immunol       Date:  2001-10-01       Impact factor: 5.422

8.  Peritumoral CpG DNA elicits a coordinated response of CD8 T cells and innate effectors to cure established tumors in a murine colon carcinoma model.

Authors:  Klaus Heckelsmiller; Katharina Rall; Sebastian Beck; Angelika Schlamp; Julia Seiderer; Bernd Jahrsdörfer; Anne Krug; Simon Rothenfusser; Stefan Endres; Gunther Hartmann
Journal:  J Immunol       Date:  2002-10-01       Impact factor: 5.422

9.  Immune cell activation by bacterial CpG-DNA through myeloid differentiation marker 88 and tumor necrosis factor receptor-associated factor (TRAF)6.

Authors:  H Häcker; R M Vabulas; O Takeuchi; K Hoshino; S Akira; H Wagner
Journal:  J Exp Med       Date:  2000-08-21       Impact factor: 14.307

10.  Potential role of phosphatidylinositol 3 kinase, rather than DNA-dependent protein kinase, in CpG DNA-induced immune activation.

Authors:  Ken J Ishii; Fumihiko Takeshita; Ihsan Gursel; Mayda Gursel; Jacqueline Conover; Andre Nussenzweig; Dennis M Klinman
Journal:  J Exp Med       Date:  2002-07-15       Impact factor: 14.307

View more
  28 in total

1.  Distinct TLR adjuvants differentially stimulate systemic and local innate immune responses in nonhuman primates.

Authors:  Marcin Kwissa; Helder I Nakaya; Herold Oluoch; Bali Pulendran
Journal:  Blood       Date:  2012-01-12       Impact factor: 22.113

2.  Activation of type I interferon-dependent genes characterizes the "core response" induced by CpG DNA.

Authors:  Folkert Steinhagen; Corinna Meyer; Debra Tross; Mayda Gursel; Takahiro Maeda; Sven Klaschik; Dennis M Klinman
Journal:  J Leukoc Biol       Date:  2012-07-02       Impact factor: 4.962

3.  DNA from Porphyromonas gingivalis and Tannerella forsythia induce cytokine production in human monocytic cell lines.

Authors:  S E Sahingur; X-J Xia; S Alamgir; K Honma; A Sharma; H A Schenkein
Journal:  Mol Oral Microbiol       Date:  2010-04       Impact factor: 3.563

4.  Altered innate immune response of plasmacytoid dendritic cells in multiple sclerosis.

Authors:  A Bayas; M Stasiolek; N Kruse; K V Toyka; K Selmaj; R Gold
Journal:  Clin Exp Immunol       Date:  2009-09       Impact factor: 4.330

5.  Toll-like receptors and opportunities for new sepsis therapeutics.

Authors:  John H Boyd
Journal:  Curr Infect Dis Rep       Date:  2012-10       Impact factor: 3.725

6.  Transcriptional profile in afferent lymph cells following vaccination with liposomes incorporating CpG.

Authors:  Melanie R Neeland; Martin J Elhay; David R Powell; Fernando J Rossello; Els N T Meeusen; Michael J de Veer
Journal:  Immunology       Date:  2015-03       Impact factor: 7.397

7.  Effect of TLR agonists on the differentiation and function of human monocytic myeloid-derived suppressor cells.

Authors:  Jing Wang; Yuko Shirota; Defne Bayik; Hidekazu Shirota; Debra Tross; James L Gulley; Lauren V Wood; Jay A Berzofsky; Dennis M Klinman
Journal:  J Immunol       Date:  2015-03-30       Impact factor: 5.422

8.  TLR-Induced Murine Dendritic Cell (DC) Activation Requires DC-Intrinsic Complement.

Authors:  Joong-Hyuk Sheen; Michael G Strainic; Jinbo Liu; Weijia Zhang; Zhengzi Yi; M Edward Medof; Peter S Heeger
Journal:  J Immunol       Date:  2017-05-24       Impact factor: 5.422

9.  Short- and long-term changes in gene expression mediated by the activation of TLR9.

Authors:  Sven Klaschik; Debra Tross; Hidekazu Shirota; Dennis M Klinman
Journal:  Mol Immunol       Date:  2009-12-14       Impact factor: 4.407

10.  Global changes in gene expression and synergistic interactions induced by TLR9 and TLR3.

Authors:  Debra Tross; Lev Petrenko; Sven Klaschik; Qing Zhu; Dennis M Klinman
Journal:  Mol Immunol       Date:  2009-06-16       Impact factor: 4.407

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.